Medical Communications

GlaxoSmithKline appointed a new area head in Thomas Willemsen to take charge of its China drug business. He succeeds Herve …

Mylan has avoided the call to testify in front of the Senate judiciary committee. The hearing will be convened under …

The Conservative Party leader has announced a planned raise in funding for research and development for UK business to £2 …

Pfizer has sued Texas’ Health and Human Services Commission, after it claimed the agency violated state and federal law by …

GlaxoSmithKline, alongside its partner Innoviva, have filed a regulatory submission with the FDA for its treatment for chronic obstructive pulmonary …

Teva Pharmaceutical announced that their drug Trisenox has been given approval from the European Commission to become the first line …

While the world is still reeling from the US presidential election results; it’s business as usual for the pharma industry; …

GlaxoSmithKline and Janssen, part of Johnson & Johnson, released the results of their two Phase III trials exploring treatment options …

Gary Tanner, former executive, and Andrew Davenport, ex-CEO of Philidor, have been arrested and charged with fraud. Preet Bharara, US …

Bristol-Myers Squibb has announced that NICE have given a Final Appraisal Determination recommending Sprycel (dasatinib) for the treatment of chronic …

The newly released app, named Echo, was developed by former Apple executive Dr Sai Lakshmi and former LloydsPharmacy executive Stephen …

Japan’s health ministry has announced it is to slash the price of Bristol-Myers Squibb’s Opdivo by 50% in the country …

Amgen released positive results from their second Phase III trial for experimental migraine drug, known as erenumab, which it is …

Shire’s Onivyde has been determined by NICE as not cost effective, in draft guidance, despite adding on average two months …

NICE has announced its approval of Roche’s Perjeta (pertuzumab) as a neoadjuvant treatment of HER2-positive, locally advanced, inflammatory or early-stage …